JPMorgan Chase & Co’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.46M | Sell |
430,108
-241,205
| -36% | -$820K | ﹤0.01% | 3524 |
|
|
2025
Q1 | $2.69M | Sell |
671,313
-276,370
| -29% | -$1.11M | ﹤0.01% | 3071 |
|
|
2024
Q4 | $6.15M | Buy |
947,683
+349,146
| +58% | +$2.27M | ﹤0.01% | 2613 |
|
|
2024
Q3 | $3.32M | Sell |
598,537
-9,903
| -2% | -$54.9K | ﹤0.01% | 2897 |
|
|
2024
Q2 | $3.4M | Buy |
608,440
+523,028
| +612% | +$2.92M | ﹤0.01% | 2762 |
|
|
2024
Q1 | $573K | Sell |
85,412
-62,184
| -42% | -$417K | ﹤0.01% | 3886 |
|
|
2023
Q4 | $1.35M | Buy |
147,596
+9,397
| +7% | +$85.7K | ﹤0.01% | 3362 |
|
|
2023
Q3 | $763K | Sell |
138,199
-6,291
| -4% | -$34.7K | ﹤0.01% | 3549 |
|
|
2023
Q2 | $1.23M | Buy |
144,490
+54,801
| +61% | +$468K | ﹤0.01% | 3299 |
|
|
2023
Q1 | $824K | Buy |
89,689
+21,414
| +31% | +$197K | ﹤0.01% | 3558 |
|
|
2022
Q4 | $697K | Buy |
68,275
+4,984
| +8% | +$50.9K | ﹤0.01% | 3574 |
|
|
2022
Q3 | $931K | Buy |
63,291
+1,837
| +3% | +$27K | ﹤0.01% | 3405 |
|
|
2022
Q2 | $659K | Buy |
61,454
+11,548
| +23% | +$124K | ﹤0.01% | 3725 |
|
|
2022
Q1 | $538K | Buy |
49,906
+39,974
| +402% | +$431K | ﹤0.01% | 3960 |
|
|
2021
Q4 | $162K | Sell |
9,932
-3,004
| -23% | -$49K | ﹤0.01% | 4639 |
|
|
2021
Q3 | $277K | Buy |
+12,936
| New | +$277K | ﹤0.01% | 4253 |
|